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Abstract
Necrotizing meningoencephalitis (NME) affects toy and small breed dogs causing progressive, often fatal, inflammation and
necrosis in the brain. Genetic risk loci for NME previously were identified in pug dogs, particularly associated with the dog
leukocyte antigen (DLA) class II complex on chromosome 12, but have not been investigated in other susceptible breeds.
We sought to evaluate Maltese and Chihuahua dogs, in addition to pug dogs, to identify novel or shared genetic risk factors
for NME development. Genome-wide association testing of single nucleotide polymorphisms (SNPs) in Maltese dogs with
NME identified 2 regions of genome-wide significance on chromosomes 4 (chr4:74522353T.A, p = 8.161027) and 15
(chr15:53338796A.G, p = 1.561027). Haplotype analysis and fine-mapping suggests that ILR7 and FBXW7, respectively, both
important for regulation of immune system function, could be the underlying associated genes. Further evaluation of these
regions and the previously identified DLA II locus across all three breeds, revealed an enrichment of nominal significant
SNPs associated with chromosome 15 in pug dogs and DLA II in Maltese and Chihuahua dogs. Meta-analysis confirmed
effect sizes the same direction in all three breeds for both the chromosome 15 and DLA II loci (p = 8.6610–11 and
p= 2.561027, respectively). This suggests a shared genetic background exists between all breeds and confers susceptibility
to NME, but effect sizes might be different among breeds. In conclusion, we identified the first genetic risk factors for NME
development in the Maltese, chromosome 4 and chromosome 15, and provide evidence for a shared genetic risk between
breeds associated with chromosome 15 and DLA II. Last, DLA II and IL7R both have been implicated in human inflammatory
diseases of the central nervous system such as multiple sclerosis, suggesting that similar pharmacotherapeutic targets
across species should be investigated.
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Introduction
Necrotizing meningoencephalitis (NME) is a disease of young to
middle aged dogs that results in a unique pattern of mononuclear
inflammation and necrosis in the brain [1]. Initially identified in
pug dogs in the late 1960 s [1], NME now has been described in
several toy and small breeds: the Brussels Griffon [2], Chihuahua
[3], Coton de Tulear [2], Maltese [4], Papillion [2], Pekingese [5],
and shih tzu [2]. The clinical course of NME is rapid and
progressive with presenting signs including seizures, altered
mentation, behavior change, circling, and visual deficits. Pre-
sumptive diagnosis of NME can be made based on clinical
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presentation, magnetic resonance imaging, and cerebrospinal fluid
analysis, but histopathological evaluation is needed for definitive
diagnosis [6]. Unfortunately, NME often is fatal despite aggressive
immunosuppressive treatment [7]. Although NME has been
recognized for over 40 years, the etiopathogenesis is poorly
understood. Initially, an infectious etiology was suspected [1] but
thorough molecular investigations have ruled out infectious causes
[8–10] and NME now is accepted to be an immune-mediated
disease that occurs as a result of genetic susceptibility [11]; to date,
no environmental triggers have been identified to contribute to
disease onset [12]. Studies focused on elucidating the etiopatho-
genesis of NME are necessary to help improve diagnosis and
treatment of this devastating disease.
Genetic susceptibility to NME has been presumed based on
over-representation of the disease in certain breeds [1,3,4]. A 2009
study confirmed heritability of NME in pug dogs [13]. This was
followed by a genome-wide scan of pug dogs with NME that
showed a strong association with the dog leukocyte antigen (DLA)
or major histocompatibility complex (MHC) class II region on
chromosome 12 [14]. We then verified these findings with an
independent cohort of pug dogs and identified a second region of
association on chromosome 8 that contains the STYX and
GNPNAT1 genes [15]. The finding of MHC II association
supports the accepted theory that NME is the result of an aberrant
immune response [7] as numerous central nervous system (CNS)
and non-CNS immune-mediated diseases have been associated
with MHC II variants in dogs and people [11,16]. Although the
exact mechanisms by which MHC II variants contribute to disease
are not understood, MHC II molecules themselves are known to
determine the reactivity of T-cells towards foreign versus self
epitopes [16]. Additionally, many genes within the MHC II
complex, such as TAP1 and TAP2, are important for normal
immune function and antigen presentation [17].
Similar to NME, multiple sclerosis is an inflammatory disease of
the CNS that has a guarded prognosis [18]. The discovery of an
MHC II association in dogs with NME led to speculation that
NME and multiple sclerosis may share a similar pathogenesis [14].
Although the clinical course of NME is more severe than classic
forms of multiple sclerosis, NME shares clinical and pathological
features with atypical forms of multiple sclerosis such as Marburg
variant [14,18]. However, it is important to note that demyelin-
ation, a key feature of multiple sclerosis pathology, is not present in
NME [1,18]. Despite this key difference, NME represents a
spontaneous model of non-infectious CNS inflammation that may
prove useful in investigations of multiple sclerosis.
The use of canine models to map disease loci has proven to be
highly effective, with fewer markers and samples needed than in
human populations. This is because each dog breed is a genetic
isolate only a few hundred years old with long-range haplotypes
across its entire genome [19]. We hypothesized that, similar to the
pug breed, Maltese and Chihuahua dogs have genetic risk factors
for NME development and that genetic risk for NME would be
shared among breeds. To identify novel and shared genetic
variants, we analyzed single nucleotide polymorphisms (SNPs)
across the genome in Maltese and Chihuahua dogs and compared
our results to an expanded population of the pug dogs that we
previously interrogated [15].
Results
Association testing
Association testing in Maltese dogs revealed two regions that
reached genome wide significance on chromosome 4
(chr4:74,522,353T.A, p= 8.0761027) and chromosome 15
(chr15:53,338,796A.G, p=1.5561027) (Table 1, Figure 1, File
S2), while association testing in Chihuahua dogs did not reveal any
regions of genome wide significance (Figure S1 in file S1). The
region identified on chromosome 4 spreads about 10 Mega-
basepairs (Mb), with the region of highest significance spanning
approximately 4.4 Mb between chr4:71,506,894-75,929,427 (Fig-
ure S2 in file S1). A tBLASTn query identified 44 human proteins
mapped to this region of the canine genome (Table S1 in file S1,
Figure 2). The second region on chromosome 15 spreads about
1.9 Mb between chr15:51,567,064-53,471,253 and using
tBLASTn, 19 human proteins mapped to this region of the
canine genome (Table S1 in file S1, Figure 2). Additionally, all
genes in these regions were prioritized based on ENDEAVOUR
gene prioritization with a training set of human multiple sclerosis
genes [20], which resulted in prioritization of IL7R on chromo-
some 4 and FBXW7 on chromosome 15 (Table S1 in file S1,
Figure 2).
We next hypothesized that these regions of genome-wide
significance identified in the Maltese breed also may contribute to
disease development in the Chihuahua and pug breeds, which
were also genotyped using the CanineHD beadchip (Illimina Inc,
San Diego, USA). For chromosome 4, genotyping of 139 SNPs in
Chihuahua dogs and 237 SNPs pug dogs only found 5 SNPs in
each (3.5% and 1.5%, respectively) that reached nominal
significance (p,0.05). However, for chromosome 15, genotyping
of 55 SNPs in Chihuahua dogs and 75 SNPs in pug dogs found 3
(3.5%) and 18 (24%) that reached nominal significance, respec-
tively. In the pug breed, this was much higher than the expected
5%, which suggests that this area of chromosome 15 also may be
important for NME susceptibility in the pug breed.
Additionally, we hypothesized that the genetic risk loci
previously identified in pug dogs on chromosome 12 and
chromosome 8 [15] may contribute to disease susceptibility in
the Maltese and Chihuahua breeds. In the Maltese, genotyping of
122 SNPs within the DLA II locus (chr12:4,713,392-8,834,652)
found 17 (13.9%) that were significant (p,0.05) (Figure S4 in file
S1), which is higher than the expected 5%. The most significant
SNP was BICF2P178662 chr12:5,166,878 (p = 0.001) (Figure 3).
In the Chihuahua, 120 SNPs were genotyped in the same region,
of which 8 were significant (6.6%) (Figure S5 in file S1). The most
significant SNP was BICF2P608380 chr12:6,289,014 (p= 0.006)
(Figure 3). On chromosome 8, where STYX and GNPNAT1 are
located (chr8:31,736,206-32,225,068), 13 SNPs were analyzed in
Maltese dogs and 9 SNPs were analyzed in Chihuahua dogs, but
none reached significance.
Fine-mapping and haplotype analysis
Fine-mapping of the regions on chr4 and chr15 identified in the
Maltese was done by a haplotype analysis, using a sliding window
of 5-SNPs across the region (Omnibus test; Figure S3 in file S1,
File S2). Based on these data, two smaller regions were selected
further for an in-depth haplotype analysis (Figure S3 in file S1;
chr4:73,000,000-77,000,000; chr15:53,000,000-54,000,000). We
performed haplotype-specific tests within the 5-SNP sliding
window in these areas, and defined additional haplotypes based
on the linkage disequilibrium (LD) structure in the region
(Figure 2). This identified specific areas of haplotypes that are
most significantly associated with NME. The most significant
haplotype on chr4 is WIN66387 (BICF2P781476|BICF2P1021800|
BICF2G630168994|BICF2G630169020|BICF2G630169045; CC-
GGG) and WIN66388 (BICF2P1021800|BICF2G630168994|
BICF2G630169020|BICF2G630169045|BICF2P633927; CGG-
GA) (p=5.7861025), located right adjacent on chr4:75916205-
76003694. These two haplotypes contain the FLJ23577 or SPEF2
Novel Risk Loci in Maltese Dogs with Necrotizing Meningoencephalitis
PLOS ONE | www.plosone.org 2 November 2014 | Volume 9 | Issue 11 | e112755
gene (Homo sapiens sperm flagellar 2), which is important in the
development of sperm, and specifically localized in germ and sertoli
cells. However, this haplotype is also located only 55kbp upstream of
IL7R, suggesting that this gene is the main factor in this region
associated with NME in the Maltese. WIN66387, CCGGG, and
WIN66388, CGGGA, were both present in 47% of the controls, and
none of the cases. This suggests that these haplotypes are protective
against NME, and other haplotypes at this position are at risk for
NME (CGAGG and GAGGA, respectively).
The most significant haplotype on chr15 is p = 7.2361028;
chr15:53287510-53338796; WIN85935 (BICF2-
S23238125|TIGRP2P203637_rs8672515|BICF2S22948103|-
BICF2S23527645|TIGRP2P203665_rs8954494; GACGG). This
haplotype contains the first part of the FBXW7 gene and a
pseudogene of the SCOC gene, which is found in multiple places of
the canine genome.
The WIN85935, GACGG haplotype is present in 47% of the
cases and 95% of the controls. Both other WIN85935 haplotypes
are at risk for developing NME (GACGA; 15% of the cases, 0 of
the controls; and AGAAA; present in 38% of the cases and 4% of
the controls).
Meta-analysis
To look more closely at the previously identified regions of
significance, we performed meta-analysis on SNPs within these
regions in Maltese, Chihuahua, and pug populations. We found
similar effect sizes for all 3 breeds for the DLA II region of
chromosome 12 (Figure 3) and the chromosome 15 locus (Figure
S6 in file S1). For the DLA II region, Figure 3 shows the SNPs that
were most significant in the Maltese (BICF2P178662), Chihuahua
(BICF2P608380), and pug (BICF2P738783 and BICF2P22942)
breeds. Power calculations show that the Maltese and Chihuahua
data-sets have 52% and 38% power, respectively to detect the
previous effect present in the pug when using an allelic test (p,
0.05) [14,21]. Meta-analysis across the entire genome only
designated the DLA II region as genome wide significant
(p = 1.1861028), followed by the region on chromosome 15
(p = 2.2361026).
Discussion
We evaluated SNPs across the genome in three toy breeds
susceptible to NME (Maltese, Chihuahua, and pug dogs) to further
characterize genetic risk for this devastating neurological disease.
Genome wide association in Maltese dogs identified risk loci
associated with NME on chromosome 4 and chromosome 15,
both of which contain genes of interest that are critical for normal
immune system function. Association testing in Chihuahua dogs
did not identify risk loci of genome wide significance, likely due to
the small sample size. Additional evaluation of the regions
identified on chromosome 4 and chromosome 15, as well as the
genetic risk loci previously identified in pug dogs with NME [15],
demonstrated that the risk locus on chromosome 15 and the DLA
II complex on chromosome 12 likely contribute to genetic
susceptibility for NME across breeds.
The most notable gene of interest within the region of
significance on chromosome 4 is IL7R, which encodes for the
interleukin (IL) 7 receptor alpha chain and is located about 68kb
from significant marker BICF2P1021800 (Table 1) and only 55kb
from the most significant region fine-mapped by haplotypes
(Figure 2). This region is located right upstream of IL7R. IL7R is
a member of the type I cytokine receptor family; it is critical for
proliferation and survival of T- and B-lymphocytes as well as
regulation of immune system function. Alterations in IL7R have
not been associated with disease in dogs, but polymorphisms in
IL7R have been demonstrated to contribute to non-MHC genetic
risk in multiple sclerosis [22,23]. Additionally, altered expression
of the genes encoding IL7Ra and its ligand, IL7, has been found in
the cerebrospinal fluid of individuals with multiple sclerosis [23].
Although a causal variant associated with IL7R has not been
identified, this finding in Maltese dogs supports the hypothesis that
NME and multiple sclerosis may share similar pathways for
disease development.
Fine-mapping of the region of chromosome 15 showed that
FBXW7 is located in the haplotype most significantly associated
with disease (Figure 2). The alpha isoform of FBXW7 is
ubiquitously expressed and has been shown to be an important
attenuator of inflammatory signaling, in part due to suppression of
CCAAT enhancer binding protein-delta (C/EBPd) [24]. Reduced
expression of C/EBPd in mice is associated with increased
expression of IL10 by dendritic cells with subsequent enhancement
of regulatory T-cells and less severe clinical disease when
experimental autoimmune encephalitis is induced by vaccination
with myelin oligodendrocyte glycoprotein [25]. Reduced expres-
sion of C/EBPd also has been associated with decreased
expression of pro-inflammatory genes in neural tissue [26].
Another gene of interest on chromosome 15 is LRBA as
deleterious mutations in LRBA have been associated with a
syndrome of immune deficiency and autoimmunity in people [27].
In addition to the identification of novel risk loci in the Maltese
breed, we identified shared risk associated with chromosome 15 as
well as the DLA II locus [14,15] by identification of enrichment of
nominal significantly associated SNPs and meta-analysis.
Figure 1. Manhattan plot of genome wide association analysis in Maltese dogs with necrotizing meningoencephalitis. The raw –log10
p-values for each SNP as determined by Fisher’s exact tests are plotted (y axis) against the chromosome position (x axis). The horizontal gray line
represents the threshold for significant association after Bonferroni correction. Regions that reach genome wide significance are indicated in black.
doi:10.1371/journal.pone.0112755.g001
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Importantly, the DLA II locus reached genome wide significance
across all breeds when genome wide meta-analysis was performed.
Since the power of the Maltese and Chihuahua datasets are low at
52% and 38%, respectively, larger sample sizes may more clearly
demonstrate a DLA II association with NME in the Maltese and
Chihuahua breeds. The identification of shared risk for NME
development in multiple toy breeds should allow for fine mapping
across breeds to identify more specific variants that result in
disease development.
In conclusion, we discovered two susceptibility loci in Maltese
dogs with NME, on chromosome 4 (chr4:75916205-76003694;
upstream of IL7R) and chromosome 15 (chr15:53287510-
53338796; FBXW7), and evidence of shared risk for NME
development in the Maltese, Chihuahua, and pug breeds.
Currently, a test for genetic susceptibility of NME in pug dogs is
commercially available to help with breeding programs [11]. The
information presented here may help with development of similar
tests in the Maltese and Chihuahua breeds. Ongoing investigations
also are aimed at identification of causal variants for NME
development with the long-term goal of developing an antemor-
tem diagnostic test as well as targeted therapies. Further studies of
these regions in other canine populations should provide an
accurate estimate of the effect size that would lead to the
implementation of a diagnostic test. Finally, the finding that IL7R,
in addition to DLA II, may be associated with NME development
supports previous theories that NME and multiple sclerosis may
have similar pathogenic mechanisms. In the future, we anticipate
that the insights gained from dogs with NME may help with
development of more personalized and effective treatments for
both NME and multiple sclerosis.
Materials and Methods
Inclusion criteria and sample collection
Samples were collected from Maltese, Chihuahua, and pug dogs
with NME. Where possible, cases of NME had histopathological
confirmation of disease diagnosis, which involved review of
hematoxylin and eosin stained sections of brain tissue by a
veterinary neuropathologist (BP and KM) for accurate diagnosis
according to previous descriptive reports [1,3,4]. Tissue collected
from these cases included archived formalin fixed paraffin
embedded (FFPE) tissue and fresh frozen brain tissue stored at
280 degrees Celsius. These tissues initially were collected from
client owned animals for owner requested necropsy. Use of these
samples in this investigation was approved by the Clinical
Research Committee at the University of Georgia, which serves
as the Veterinary Teaching Hospital’s internal review board for all
clinical research involving client owned animals.
When brain tissue was not available for histopathological
confirmation, a presumptive diagnosis of NME was made using
the following inclusion and exclusion criteria. Included dogs had to
meet all of the following criteria: purebred Maltese or Chihuahua
with pedigree information provided by the owner; 6 months to 7
years of age at time of disease onset; clinical signs present for less
than 2 weeks; neuroanatomic localization to the prosencephalon
with or without concurrent localization to the cerebellum or
brainstem; MRI findings consistent with previously described
reports as outlined below; a mononuclear pleocytosis of greater
than 5 white blood cells per microliter in an atlantooccipital or
lumbar cerebrospinal fluid (CSF) sample with no identifiable
infectious agents or lymphoblasts; and negative antibody titers to
Neospora caninum, Toxoplasma gondii, and Ehrlichia canis in
serum or CSF. On MRI, dogs were required to have ill defined
multifocal to diffuse, asymmetric lesions affecting the gray and
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white matter of the cerebral hemispheres that had to be
hyperintense on T2-weighted and fluid-attenuated inversion
recovery images and iso- to hypointense on T1-weighted images.
Concurrent T2 hyperintensities in the cerebellum and brainstem
could be present as long as lesions in these locations comprised less
than 80% of the total lesion burden on MRI. Variable MRI
findings included mass effect such as shift of the falx cerebri, brain
herniation, and mild to moderate contrast enhancement of the
brain parenchyma or leptomeninges. Dogs with strong contrast
enhancement or peripheral rim enhancement were excluded [28].
Dogs also were excluded if they had evidence of systemic illness
such as organ dysfunction, neoplasia, or infection based on a
complete blood count, serum biochemistry, urinalysis, and three
view thoracic radiographs; evidence of spinal cord disease on
neurological exam or MRI; or evidence of neuromuscular disease
on neurological exam.
Control dogs were determined by a veterinarian to be healthy at
the time of sample collection had no history of autoimmune or
neurological disease. Control dogs of the Maltese and Chihuahua
breeds were all greater than 60 months of age at the time of
sample collection and were followed for an additional 24 months
to ensure they remained disease free until 84 months of age, after
which time development of NME is unlikely. Control dogs of the
pug breed ranged in age from 5 to 204 months (mean 60 months)
at the time of sample collection. All control pugs aside from 2 that
were lost to follow-up were followed for 60 months after sample
collection to verify that they did not develop neurological or
autoimmune disease; 13 control pugs all over the age of 84 months
had died of other disease processes at the time of writing this
paper. All presumptive NME cases and healthy controls were
included with their owner’s consent and samples (1ml of whole
blood or cheek swab of saliva) were obtained in strict accordance
with good animal practice. The study protocol was approved by
the University of Georgia Institutional Animal Care and Use
Committee (IACUC number A2010 09-165-Y2-A0) and the
IACUC of TGen Drug Development (TD2; protocol number
14010).
Study population
In total, 196 samples from purebred Maltese, Chihuahua, and
pug dogs were used for analysis. Samples from Maltese dogs were
used for genome wide association and meta-analysis and included
8 with histopathologically confirmed NME, 3 with presumptive
NME, and 38 healthy controls. Maltese dogs with NME included
5 females and 6 males. Healthy controls of the Maltese breed
included 20 females and 18 males. Samples from Chihuahua dogs
were used for genome wide association and meta-analysis and
included 14 with histopathologically confirmed NME, 2 with
presumptive NME, and 9 healthy controls. Chihuahua dogs with
NME included 9 females and 7 males. Healthy controls of the
Chihuahua breed included 6 females and 3 males. Additionally, 34
pug dogs with histopathologically confirmed NME and 88 healthy
control pug dogs were utilized for genotyping and meta-analysis.
These pug dogs were an expansion of the dataset used by Barber
Figure 2. Fine mapping of genome wide significant regions on (A) chromosomes 4 and (B) 15 in Maltese dogs by haplotype
analysis. The raw –log10 p-values for each haplotype test are plotted (y axis) against the chromosome position (x axis). The colored lines represent
haplotypes formed by a 5-SNP sliding window across the region, and the black lines represent haplotypes formed by the underlying LD structure
calculated by the 4-gamete rule. In the bottom, the LD between the SNPs in the region is shown (dark red = high D’; blue = low D’). The haploblocks
based on the 4-gamete rule are indicated in black.
doi:10.1371/journal.pone.0112755.g002
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et al. in 2011 [15] and included 22 females and 12 males with
NME as well as 48 females and 40 males that served as healthy
controls.
DNA preparation and genotyping
Genomic DNA was extracted from whole blood, saliva, fresh
frozen brain tissue, or FFPE tissue sections. Extraction from
EDTA blood samples and fresh frozen brain tissue was performed
with the DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA,
USA). Saliva samples were extracted using the Oragene saliva
extraction protocol (DNA Genotek, Ontario, Canada). Extraction
from FFPE tissues utilized the QIAamp DNA FFPE Tissue Kit
(Qiagen, Valencia, CA, USA) followed by whole genome
amplification with the Ovation WGA FFPE system (NuGEN,
San Carlos, USA). Samples were genotyped using the CanineHD
beadchip, following manufacturer’s instructions (Illumina Inc, San
Diego, USA).
Statistical Analysis
A total of 173,662 SNPs were genotyped in all cases and
controls and analysis was performed with PLINK v1.07 [29].
Pairwise identity by decent estimation was done to remove
possibly related dogs (Pi_hat score.0.5 were excluded), leading to
the exclusion of 1 Maltese control (Pi_hat score 0.64). Next,
multidimensional scaling (MDS) with a minor allele frequency
(MAF) of .0.10 and genotype frequency .97% was performed to
determine population stratification, and 2 Maltese controls that
were not clustered with the main population of dogs were excluded
resulting in a final population of 11 Maltese NME cases and 35
Maltese controls for analysis. Further testing of population
stratification was done on this sample set by plotting a QQ plot
of observed against expected p-values, resulting in a genomic
inflation factor of 1.025, or 1.0004 when corrected for the two
associated regions (Figure S7 in file S1), demonstrating no
significant population stratification in the sample set. Two affected
pug dogs and 44 control pug dogs were excluded based on MDS,
resulting in 32 NME cases and 44 controls for final analysis. No
Chihuahuas were excluded based on population structure analysis,
resulting in 16 NME cases and 9 controls for final analysis.
All had call rates of .80% and were included in the analysis.
After excluding SNPs with a call rate ,97%, MAF of ,0.10, and
Hardy-Weinberg equilibrium of .0.001 as well as SNPs on the X
and Y chromosomes, a total of 57,222 SNPs were analyzed using
Fisher’s exact tests for comparison of allelic frequency (for the
Maltese dataset). A Bonferroni correction for multiple testing was
performed with a resulting p-value of 8.761027 across 57,222
SNPs for genome-wide significance. To further evaluate genome-
wide significance MaxT permutation testing of 10,000 permuta-
tions and a false discover rate correction were applied [30]. All
plots were created using R2.15.3 packages qqman and ggplot2
(http://www.r-project.org). Regions of interest were defined by
SNPs reaching genome wide significance and surrounding SNPs
with a suggestive p= 161024 significance.
Figure 3. Forest plots of four SNPs in the dog leukocyte antigen II region on chromosome 12 across three toy breeds with
necrotizing meningoencephalitis. (a) BICF2P22942: p = 1.5761027, OR= 0.18 (0.09–0.35), (b) BICF2P738783: p = 4.1161028, OR= 0.18 (0.10–0.34),
(c) BICF2P178662: p = 1.1161029, OR= 9.48 (4.19–21.40), and (d) BICF2P608380: p = 8.6610211, OR= 11.08 (4.72–26.01). The 95% confidence interval
for each study is represented by a horizontal line, and the point estimate is given by a square, the height of which is inversely proportional to the
standard error of the estimate after each study. The summary OR is indicated by a diamond with horizontal limits as the confidence limits and height
inversely proportional to its standard error. The meta-analyses for all these SNPs were significant and effect sizes were in the same direction.
doi:10.1371/journal.pone.0112755.g003
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Haplotype analysis
The regions on chromosome 4 and 15 in the Maltese were
further fine-mapped by haplotype analysis. This was done with
PLINK v1.07 [29], by using a 5-SNP sliding over the region of
interest. In addition, haploblocks were chosen with Haploview
based on the underlying LD structure of the region [31]. The four-
gamete rule with a fourth haplotype frequency cutoff of 0.1 was
used to define haploblocks based on LD [31].
Meta-analysis
To calculate the common effect size of SNPs across the three
breeds, meta-analysis and corresponding forest plots were
performed using the R package Rmeta and R2.15.3 (http://
www.r-project.org). A logistic regression model was used to
estimate the common odds ratio with origin and genotype as
independent variables and outcome as a dependent variable (the
Mantel-Haenszel method). In addition, genome wide meta-
analysis was performed using PLINK v1.07 [29]. Power calcula-
tions were done using the genetic power calculator [21], assuming
29% carrier frequency, a relative risk of 5.45 in the homozygotes,
a disease frequency of 1%, and considering unscreened random
controls [14].
Supporting Information
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